Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 138,473 | 142,733 | 68,830 | 71,756 | 37,486 |
| Marketable Securities | 50,734 | 50,119 | 0 | 0 | 25,858 |
| Receivables | 18,388 | 23,773 | 23,991 | 21,313 | 31,937 |
| Other current assets | 15,486 | 12,813 | 0 | 13,815 | 8,542 |
| TOTAL | $223,080 | $229,438 | $103,213 | $106,884 | $103,823 |
| Non-Current Assets | |||||
| PPE Net | 2,132 | 2,261 | 2,310 | 2,351 | 2,571 |
| Investments And Advances | 359 | 359 | 362 | 347 | 358 |
| Intangibles | 10,029 | 10,108 | 10,349 | 9,917 | 10,185 |
| Other Non-Current Assets | 2,986 | 3,238 | 3,287 | 0 | 0 |
| TOTAL | $15,506 | $15,966 | $16,307 | $12,615 | $13,114 |
| Total Assets | $238,586 | $245,403 | $119,520 | $119,498 | $116,937 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,962 | 13,240 | 3,349 | 14,574 | 15,384 |
| Accrued Expenses | N/A | N/A | 11,274 | N/A | N/A |
| TOTAL | $22,693 | $17,897 | $22,636 | $21,982 | $24,667 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,498 | 4,425 | 6,575 | 7,163 | 9,033 |
| TOTAL | $73,595 | $71,080 | $75,164 | $73,116 | $76,811 |
| Total Liabilities | $96,288 | $88,977 | $97,800 | $95,099 | $101,478 |
| Shareholders' Equity | |||||
| Common Shares | 8,878 | 8,820 | 7,570 | 7,077 | 6,952 |
| Retained earnings | -404,925 | -385,951 | -388,046 | -354,565 | -356,649 |
| Other shareholders' equity | 80,399 | 77,592 | 75,261 | 70,745 | 68,715 |
| TOTAL | $142,299 | $156,426 | $21,720 | $24,399 | $15,459 |
| Total Liabilities And Equity | $238,586 | $245,403 | $119,520 | $119,498 | $116,937 |